Sign in to view content

Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials

Caroline Baumal, MD, FASRS

Video
Published 2021

Related

Episode 110: June 2018 Issue of Retinal Physician with Dr. Will Parke
Jayanth Sridhar, MD
Member Podcasts
2018
Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2021
IL-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Phase 3 MEERKAT and SANDCAT Trials
Anat Loewenstein, MD
Annual Meeting Talks
2024

Category: Diabetic Retinopathy

See more